On a mission to make organ transplants safer and more durable, Blackstone gifts Talaris a new CEO, leads $100M round

ENDPOINTS NEWS: As a transplant surgeon by training, Suzanne Ildstad understood the plight of her patients all too well: The risk of organ rejection forces them to adopt immunosuppression regimens, which in turn expose them to infections and cardiovascular problems they have to contend with. She knew that if the bone marrow from a donor takes, any subsequent organ transplant would, too. FULL STORY